More importantly, we demonstrate, for the first time, that PRC1 can be targeted by piperlongumine (PL), an agent that has been previously proved to suppress gastric cancer cells by our group 17, via a p53‐dependent mechanism. The gene discussed is PRC1; the disease is gastric cancer.